- Report
- April 2025
- 178 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 178 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 275 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 242 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 72 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 293 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 573 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 92 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 89 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 88 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 88 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 196 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 179 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 196 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 263 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 216 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 174 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 221 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 480 Pages
Global
From €5324EUR$5,850USD£4,522GBP

Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease.
Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more